Andrew Catchpole

Immunosenescence and human vaccine immune responses

Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection

Messenger RNA-Based Vaccines Against Infectious Diseases

Canine coronavirus inactivation with physical and chemical agents

Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

SARS-CoV-2 in wastewater: State of the knowledge and research needs

Hierarchy among Viral RNA (vRNA) Segments in Their Role in vRNA Incorporation into Influenza A Virions

Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation

Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B

The Morphology and Composition of Influenza A Virus Particles Are Not Affected by Low Levels of M1 and M2 Proteins in Infected Cells

New Kids on the Block: RNA-Based Influenza Virus Vaccines

Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America

The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

A Throat Lozenge Containing Amyl Meta Cresol and Dichlorobenzyl Alcohol Has a Direct Virucidal Effect on Respiratory Syncytial Virus, Influenza a and SARS-CoV

New Antiviral Drugs, Vaccines and Classic Public Health Interventions against SARS Coronavirus

Alternative base pairs attenuate influenza A virus when introduced into the duplex region of the conserved viral RNA promoter of either the NS or the PA gene